The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury
Open accessAbstract
Acute lung injury (ALI) is a severe illness with excess mortality and no specific therapy. In its early exudative phase, neutrophil activation and accumulation in the lung lead to hypoxemia, widespread tissue damage, and respiratory failure. In clinical trials, inhibition of proinflammatory mediators has not proven effective. In this study, we pursued a new investigative strategy that emphasizes mediators promoting resolution from lung injury. A new spontaneously resolving experimental murine model of ALI from acid aspiration was developed to identify endogenous proresolving mechanisms. ALI increased cyclooxygenase 2 (COX-2) expression in murine lung. Selective pharmacologic inhibition or gene disruption of COX-2 blocked resolution of ALI. COX-2-derived products increased levels of the proresolving lipid mediators lipoxin A4 (LXA4) and, in the presence of aspirin, 15-epi-LXA4. Both LXA4 and 15-epi-LXA4 interact with the LXA4 receptor (ALX) to mediate anti-inflammatory actions. ALX expression was markedly induced by acid injury and transgenic mice with increased ALX expression displayed dramatic protection from ALI. Together, these findings indicate a protective role in ALI for COX-2-derived mediators, in part via enhanced lipoxin signaling, and carry potential therapeutic implications for this devastating clinical disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Acute Respiratory Distress Syndrome
Matthay, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342209 · Cited by 4,923
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,631
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
Robbins pathologic basis of disease
Cotran, R. S., Kumar, V., & Collins, T. (1989) · Medical Entomology and Zoology · Cited by 1,944
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
High-Dose Corticosteroids in Patients with the Adult Respiratory Distress Syndrome
Bernard, G. R., Luce, J. M., Sprung, C. L., Rinaldo, J. E., Tate, R. M., Sibbald, W. J., Kariman, K., Higgins, S., Bradley, R., Metz, C. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172504 · Cited by 935
Clinical risks for development of the acute respiratory distress syndrome.
Hudson, L. D., Milberg, J. A., Anardi, D., & Maunder, R. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.2.7842182 · Cited by 890
The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis
Bernard, G. R., Wheeler, A. P., Russell, J. A., Schein, R., Summer, W. R., Steinberg, K. P., Fulkerson, W. J., Wright, P. E., Christman, B. W., Dupont, W. D., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361303 · Cited by 837
Failing the Public Health — Rofecoxib, Merck, and the FDA
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048286 · Cited by 599
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W., Drazen, J. M., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm748 · Cited by 352
Self-citationAcute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2
Nagase, T., Uozumi, N., Ishii, S., Kume, K., Izumi, T., Ouchi, Y., & Shimizu, T. (2000) · Nature Immunology · doi:10.1038/76897 · Cited by 302
Lipoxin biosynthesis and its impact in inflammatory and vascular events
Serhan, C. N. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90185-6 · Cited by 273
The ARDS Network Authors for the ARDS Network (2000) · JAMA · doi:10.1001/jama.283.15.1995 · Cited by 264
Donnelly, S. C., Strieter, R. M., Reid, P. T., Kunkel, S. L., Burdick, M. D., Armstrong, I., Mackenzie, A., & Haslett, C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-3-199608010-00005 · Cited by 255
Investigating antibody-catalyzed ozone generation by human neutrophils
Babior, B. M., Takeuchi, C., Ruedi, J., Gutierrez, A., & Wentworth, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530251100 · Cited by 211
Serhan, C. N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00047-3 · Cited by 205
Allergic lung responses are increased in prostaglandin H synthase–deficient mice
Gavett, S. H., Madison, S. L., Chulada, P. C., Scarborough, P. E., Qu, W., Boyle, J. E., Tiano, H. F., Lee, C. A., Langenbach, R., Roggli, V. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6890 · Cited by 196
Devchand, P. R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R., Gronert, K., & Serhan, C. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0770com · Cited by 176
Mechanical Stress Triggers Selective Release of Fibrotic Mediators from Bronchial Epithelium
Tschumperlin, D. J., Shively, J. D., Kikuchi, T., & Drazen, J. M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0121oc · Cited by 157
Celecoxib activates a novel mitochondrial apoptosis signaling pathway
Jendrossek, V., Handrick, R., & Belka, C. (2003) · The FASEB Journal · doi:10.1096/fj.02-0947fje · Cited by 141
Cyclooxygenase-2–derived lipoxin A4 increases gastric resistance to aspirin-induced damage
Fiorucci, S., de Lima, O. M., Mencarelli, A., Palazzetti, B., Distrutti, E., McKnight, W., Dicay, M. S., Ma, L., Romano, M., Morelli, A., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36558 · Cited by 137
Bandeira‐Melo, C., Serra, M. F., Diaz, B. L., Cordeiro, R. S. B., Silva, P., Lenzi, H. L., Bakhle, Y. S., Serhan, C. N., & Martins, M. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1029 · Cited by 135
Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death
江島, 邦., Layne, M. D., Carvajal, I. M., Kritek, P., Baron, R. M., Chen, Y., Saal, J. V., Levy, B. D., Yet, S., & Perrella, M. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-1078fje · Cited by 122
Self-citationPouliot, M., Gilbert, C., Borgeat, P., Poubelle, P. E., Bourgoin, S. G., Créminon, C., Maclouf, J., McColl, S. R., & Naccache, P. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1109 · Cited by 118
Ventilator-induced lung injury: in vivo and in vitro mechanisms
Matthay, M. A., Bhattacharya, S., Gaver, D. P., Ware, L. B., Lim, L. H. K., Syrkina, O. L., Eyal, F. G., & Hubmayr, R. D. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00154.2002 · Cited by 107
Molecular and Cellular Basis of Inflammation
(1999) · Humana Press eBooks · doi:10.1007/978-1-59259-253-1 · Cited by 102
Hashimoto, K., Sheller, J. R., Morrow, J. D., Collins, R. D., Goleniewska, K., O’Neal, J. F., Zhou, W., Ji, S., Mitchell, D. B., Graham, B. S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.525 · Cited by 42
Heme Oxygenase 1 in Regulation of Inflammation and Oxidative Damage
Yet, S., Melo, L. G., Layne, M. D., et al. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)53046-9 · Cited by 40
Induction of Cyclooxygenase-2 in Alveolar Macrophages after Acid Aspiration
Ohara, M., Sawa, T., Kurahashi, K., Wiener-Kronish, J. P., Doshi, V., Kudoh, I., & Gropper, M. A. (1998) · Anesthesiology · doi:10.1097/00000542-199804000-00022 · Cited by 18
Cited by
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
Self-citationResolution of Inflammation: What Controls Its Onset?
Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00160 · Cited by 638
Multifaceted roles of PGE2 in inflammation and cancer
Nakanishi, M., & Rosenberg, D. W. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0342-8 · Cited by 591
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Metadata
- Authors
- Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L. E., & Levy, B. D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04
- Volume
- 174
- Issue
- 8
- Pages
- 5033-5039
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1913937884
- Cited by
- 275
- References
- 35
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.